Study of ovarian cancer outcomes in treatment-resistant cases
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This research study follows patients with epithelial ovarian cancer that has returned or worsened quickly after treatment (within 6 months). The goal is to understand survival patterns and outcomes in these difficult-to-treat cases to potentially improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Confirmed diagnosis of epithelial ovarian cancer, fallopian tube cancer, or peritoneal cancer (the tissue lining the abdomen)
- Cancer returned or progressed within 6 months of previous treatment
- Age 18 or older
- Good enough overall health to participate (able to carry out daily activities with minimal assistance)
- Willing to sign consent allowing your medical data to be used for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain “DNA repair traits” (called homologous recombination phenotype) in people with epithelial ovarian cancer. Results may help researchers better understand who responds to platinum chemotherapy, which is commonly used for this cancer.
This registry collects information from people with advanced ovarian or endometrial cancer to better understand care and outcomes. It may help researchers and doctors learn which treatments work best for different patients.
This Phase 1 study tests whether giving your own immune cells—engineered to target the FSH receptor—can control recurrent ovarian-related cancers. It’s mainly looking at safety and early signs of activity for patients whose cancer has not responded well to standard platinum chemotherapy.
This study looks at the real-world experiences of patients with ovarian cancer, whether newly diagnosed or with persistent or recurrent disease. It aims to learn more about the disease and its treatment over time.
This trial checks whether having surgery to remove as much tumor as possible, followed by ongoing targeted treatment, helps people with advanced ovarian (and related) cancers live longer and/or control cancer better. It specifically uses tumor-testing results to match patients and then continues treatment after surgery.
This study looks at ovarian cancer patients who are planned to receive platinum-based chemotherapy and who may have resistance issues. It may help doctors learn better ways to treat ovarian cancer when platinum drugs don’t work well.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.